U.S. Food and Drug Administration

@us_fda · 199,000 subscribers

View the channel on YouTube

Median views per long-form video

302

Uploads per week

6.3

Average long-form length

1:31:16

In the sample

46 long-form · 4 Shorts

Beat the channel median

Cellular, Tissue and Gene Therapies Advisory Committee (CTGTAC) Meeting
15.4K views · 50.9x the median
Expedited Investigational New Drug (IND) pilot program webinar
6.2K views · 20.7x the median
Day 1 - Public Meeting on Listeria monocytogenes Prevention
4K views · 13.2x the median
Navigating the FDA Bayesian Draft Guidance: Design, Analysis, and Review Considerations
3.1K views · 10.3x the median
Day 2 - Public Meeting on Listeria monocytogenes Prevention
2.8K views · 9.1x the median

Trailed the channel median

GDF2026 - Factors that Can Facilitate Assessment of Type II Drug Master Files (DMFs)
70 views · 0.2x the median
GDF2026 - Decoding PSGs for Complex Non-Oral Generics
59 views · 0.2x the median
GDF2026 - Product-Specific Guidances (PSGs) in Action – Key Lessons and Common Questions
57 views · 0.2x the median
GDF2026 - Q&A Discussion Panel Three
50 views · 0.2x the median
GDF2026 - Q&A Discussion Panel Five
26 views · 0.1x the median

Latest uploads

The 50 most recent uploads, newest first. Shorts are included; the badge marks them.

Title	Published	Length	Views
CDRH: Molecular and Clinical Genetics Panel of the Medical Devices Advisory Committee (MDAC)	Sep 23, 2026	8:59:50	15.7K
Scientific Workshop: Next-Generation Sequencing for Adventitious Agent Detection in Biologics	Sep 23, 2026	8:21:33	3.2K
Part Three: Substantial Equivalence (SE): The Predicate Review Process, Amendments, and Outcomes	Sep 21, 2026	16:48	439
Part Two: Substantial Equivalence (SE): Reviewing Predicate Tobacco Eligibility	Sep 21, 2026	14:11	317
Part One: Substantial Equivalence (SE): Key Concepts and Overview of The SE Review Process	Sep 21, 2026	13:47	436
Testosterone Use in Menopausal Women	Sep 17, 2026	7:19:47	32.8K
Pediatric Advisory Committee Meeting	Sep 16, 2026	6:12:46	2.1K
Considerations for Potential Future Therapeutic Use of Psychedelic Drugs Public Hearing	Sep 14, 2026	3:57:31	18.6K
Tips to Stay Safe in the SunShort	Sep 10, 2026	0:31	503
Sun Safety for Baby: Protect your little onesShort	Sep 10, 2026	0:34	406
Tips to Stay Safe in the SunShort	Sep 10, 2026	0:54	669
Sun Safety for Baby: Protect your little onesShort	Sep 10, 2026	0:58	631
FDA Patient-Focused Drug Development Meeting for Nonhealing Chronic Wounds	Aug 26, 2026	5:14:20	2.7K
FDA Draft Guidance on Potency Assessment of Active Immunotherapy Products	Aug 24, 2026	10:02	1.7K
Day 2 - Public Meeting on Listeria monocytogenes Prevention	Aug 19, 2026	5:05:30	2.8K
Day 1 - Public Meeting on Listeria monocytogenes Prevention	Aug 18, 2026	4:34:11	4K
Navigating the FDA Bayesian Draft Guidance: Design, Analysis, and Review Considerations	Aug 17, 2026	27:14	3.1K
FDA Grand Rounds-The Role of FDA in Preventing Medication Errors	Aug 14, 2026	45:08	861
Expedited Investigational New Drug (IND) pilot program webinar	Aug 7, 2026	52:42	6.2K
Draft Guidance: Leveraging Prior Knowledge in the Development of Human GT Products Incorporating GE	Jul 31, 2026	22:45	1.5K
Cellular, Tissue and Gene Therapies Advisory Committee (CTGTAC) Meeting	Jul 30, 2026	7:40:55	15.4K
GDF2026 - Closing Remarks	Jul 30, 2026	4:28	1.1K
GDF2026 - Q&A Discussion Panel Eight	Jul 30, 2026	21:28	304
GDF2026 - Manufacturing Deficiencies in Liquid Drug Products: The Top Ten Issues	Jul 30, 2026	20:30	828
GDF2026 - Recent Trends in Pharmaceutical Freeze-Drying and Control Strategies	Jul 30, 2026	14:25	526
GDF2026 - Bioanalysis of Endogenous Drugs Using Surrogate Matrix Approach in ANDAs	Jul 30, 2026	23:58	408
GDF2026 - ICH M13A High-Risk vs. Low-Risk Case Studies – Bioequivalence (BE) Implications	Jul 30, 2026	18:53	407
GDF2026 - Q&A Discussion Panel Seven	Jul 30, 2026	19:50	212
GDF2026 - Quality and Safety Assessment of Extractables/Leachables in Generic Drug Products	Jul 30, 2026	22:57	670
GDF2026 - Updates on Nitrosamines/ Nitrosamine Mitigation Strategies for Pharmaceuticals	Jul 30, 2026	21:04	555
GDF2026 - Bioequivalence (BE) Recommendations for Bridging Pre- and Post-Mitigation Formulations	Jul 30, 2026	20:21	315
GDF2026 - Best Practices for Safety Assessment of Nitrosamines in Generic Drugs	Jul 30, 2026	16:52	204
GDF2026 - Q&A Discussion Panel Six	Jul 30, 2026	9:42	217
GDF2026 - Q&A Discussion Panel Two	Jul 30, 2026	18:59	100
GDF2026 - Common Microbiology Deficiencies for Ophthalmic Suspension Drug Products	Jul 30, 2026	17:56	300
GDF2026 - Data Integrity in ANDA Applications	Jul 30, 2026	21:16	185
GDF2026 - Common Manufacturing Deficiencies for Complex Dosage Forms	Jul 30, 2026	25:16	305
GDF2026 - Managing Your Letters of Authorization (LOAs)	Jul 30, 2026	14:40	207
GDF2026 - Regulatory Review Process for Type II Secondary DMFs	Jul 30, 2026	19:36	113
GDF2026 - Pre-Abbreviated New Drug Application (ANDA) Meetings for Complex Drug Products	Jul 30, 2026	17:31	95
GDF2026 - Q&A Discussion Panel Five	Jul 30, 2026	29:06	26
GDF2026 - Factors that Can Facilitate Assessment of Type II Drug Master Files (DMFs)	Jul 30, 2026	17:37	70
GDF2026 - Q&A Discussion Panel Four and Day One Closing	Jul 30, 2026	20:10	126
GDF2026 - Drug-Device Combination Products: A Quality Perspective	Jul 30, 2026	20:23	84
GDF2026 - Product-Specific Guidances (PSGs) in Action – Key Lessons and Common Questions	Jul 30, 2026	17:34	57
GDF2026 - Decoding PSGs for Complex Non-Oral Generics	Jul 30, 2026	20:10	59
GDF2026 - Overview of the FDA Product-Specific Guidance (PSG) Program	Jul 30, 2026	23:30	139
GDF2026 - Q&A Discussion Panel Three	Jul 30, 2026	19:28	50
GDF2026 - Orange Book: How Drug Product Listings are Added, Updated, and Maintained	Jul 30, 2026	16:24	85
GDF2026 - Addressing Patent and Exclusivity Requirements – Regulatory Reminders	Jul 30, 2026	15:45	84

Transcripts on Prepublish

Transcripts of this channel's videos that have already been read from YouTube's own caption tracks.

Testosterone Use in Menopausal Women19,351 words

See what separates this channel's best and worst videos

The free channel scan reads this channel's public videos and transcripts and reports the patterns behind its winners and losers, with verbatim quotes. Free, no signup.

Run the free channel scan

Writing a video like these? Check the script before you record.

Where these numbers come from

Counts from the YouTube Data API, read Sep 24, 2026. Refreshed at least every 7 days. The sample covers uploads published Jul 30, 2026 to Sep 23, 2026. A channel that would rather this page did not exist can ask for its removal through the contact page, and it is removed.

YouTube channel stats

Reading the channel

Pulling the latest uploads from YouTube. This usually takes a few seconds.